Special Drug Use Investigation for LAMICTAL Bipolar
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2016
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 21 Apr 2016 Status changed from not yet recruiting to completed.
- 29 Mar 2015 Planned End Date changed from 1 Sep 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
- 29 Mar 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov record.